由METTL7B诱导的组素乳化通过改善心脏重塑来预防心力衰竭
Ziqi Chen1, Meijun Zhong1, Yuhui Lin1
1Department of Cardiology, Translational Research Center for Regenerative Medicine and 3D Printing Technologies, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Journal of molecular and cellular cardiology
|March 11, 2025
概括
一种新型调节剂METTL7B通过促进基因素乳化来缓解心脏重塑. 它在多变性心肌病中的降低调节表明METTL7B是心力衰竭的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 疾病的分子机制.
背景情况:
- 基因酸乳化对生物功能至关重要,其中I类基因酸脱化酶 (HDAC1-3) 被确定为基因素脱化酶.
- 乳化在心脏重塑中的确切作用在很大程度上仍未被探索.
- 了解乳糖调节是开发心脏病治疗新治疗策略的关键.
研究的目的:
- 为了确定新兴的组织素乳酸化调节剂.
- 阐明这些调节器在心脏重塑和心力衰竭中的功能机制.
- 探索METTL7B作为心肌功能障碍的潜在治疗标.
主要方法:
- 分析了来自高性心肌病 (HCM) 患者的基因表达数据 (GSE36961,GSE141910,GSE174691).
- 重量基因共同表达网络分析 (WGCNA) 和差异基因表达分析确定了候选基因.
- 使用qRT-PCR和西部涂抹验证了METTL7B的表达;其功能通过HCM和小鼠模型中的免疫光,免疫沉和RNA拉下测试来评估.
主要成果:
- 在高缩心肌中,METTL7B的表达显著下调.
- 心脏乳化水平最初增加,然后在心脏重塑过程中降低.
- METTL7B缓解了心脏重塑和改善了心脏功能,可能是通过维持质母乳化激活和抑制USP38表达,导致HDAC3.3的无处不在性增加.
结论:
- 鉴定出METTL7B是心肌乳化的一个关键调节剂.
- METTL7B在促进心肌乳化方面发挥着关键作用,这对心脏功能有益.
- 在心力衰竭中,METTL7B是减轻心脏重塑和改善心脏功能的有希望的治疗标.
更多相关视频
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:22Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318